Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P19 ppsx
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P19 ppsx
... spherical and non-spherical microparticles (e.g.,
PVA particles and tris-acryl gelatin microspheres), and absolute alcohol. Choosing
a particular embolic agent is at the operator
s discretion, and ... Madoff and R. Avritscher
e
c
a
f
d
b
Fig. 11.5 A 72-year-old man with history of hepatitis B, cirrhosis, and hepatocellular carcinoma
HCC, who had transhepatic ipsilateral RPVE w...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P5 ppsx
... Bianchi L (1993) Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr
152(Suppl 1):S63–S70
54. Kowdley KV (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology
127:S79–S86
55. ... Ohshima S, Goto T, et al (2007)
Non-alcoholic steatohepatitis and hepatocellular carcinoma: lessons from hepatocyte-specific
phosphatase and tensin homolog (PTEN...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P6 ppsx
... inclusions, and fibrinogen
containing pale bodies, presenting as pale ground-glass cytoplasmic inclusions
[24, 36, 41].
Combined Hepatocellular Carcinoma and Cholangiocarcinoma
Combined HCC and cholangiocarcinomas ... patients develop recurrence within 1 year and die
3 Hepatocellular Cancer: Pathologic Considerations 39
Fig. 3.3 Pseudoglandular
(acinar) pattern of
hepatocellular...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P18 ppsx
... patient’s age and comorbidities (e.g., diabetes) that may affect hypertrophy
and perioperative outcome. Thus, after all of these factors have been evaluated and
the patient remains a candidate for ... direction
162 D.C. Madoff and R. Avritscher
may develop hepatic injuries such as steatohepatitis and sinusoidal dilatation from
oxaliplatin and irinotecan-based fluoropyrimidine chemo...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P40 ppsx
... Karapanagiotou LM, Pandha H et al (2008) Targeted therapy for advanced renal
cell cancer: cytokines and beyond. Curr Pharm Des 14:2229–2251
28. Rini BI, Flaherty K (2008) Clinical effect and future considerations ... fluo-
rouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335–2342
Chapter 24
Follow-Up and Salvage Therapy for Recurrent
Hepatocellular C...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P43 pdf
... 372t
Treatment algorithm for HCC (Japan), 90f
advanced cancer
chemotherapy, 93
TACE and liver resection, 93
degree of liver damage A and B
liver resection/percutaneous ablation
treatment, two/three ... 114
postoperative mortality,
114
M.D. Anderson Cancer Center, criteria for
resection, 110t
patient selection/preparation, 110
preoperative therapy
chemotherapy, 118–120
PVE, perioperative...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P1 doc
... both
environmental and chronic medical conditions. These emerging factors, such as
v
Kelly M. McMasters
Jean-Nicolas Vauthey
Editors
Hepatocellular Carcinoma
Targeted Therapy and Multidisciplinary ... Texas
January 2010
vii
Foreword
It is a great pleasure and an honor to write the preface for this outstanding book
dedicated to the therapy of hepatocellular carcinoma (HCC). T...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P2 potx
... Pritesh Mutha, and Sanjay Gupta
21 Cytotoxic Chemotherapy and Endocrine Therapy
for Hepatocellular Carcinoma 337
Daniel Palmer and Philip J. Johnson
22 Targeted Therapies for Hepatocellular Carcinoma ... Albany, and Ghassan K. Abou-Alfa
23 The Future: Combination Systemic Therapy
for Hepatocellular Carcinoma 369
Ahmed O. Kaseb and Melanie B. Thomas
24 Follow-Up and Sal...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P3 pot
... calcula-
tion and definition of obesity. Results from an ongoing case–control s tudy indicated
1 Epidemiology and Pathogenesis of Hepatocellular Carcinoma 13
6. El-Serag HB, Rudolph KL (2007) Hepatocellular ... compounds: B
1
,B
2
,G
1
,
and G
2
[55]. The most common and most toxic AF is AFB
1
, and the most important
target organ is the liver, where the toxicity can lead to live...
Hepatocellular Carcinoma: Targeted Therapy and Multidisciplinary P4 potx
... of alcohol, diabetes, and
viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer
101:1009–1017
1 Epidemiology and Pathogenesis of Hepatocellular Carcinoma ... genes and miRNAs in biological pathways. Furthermore, signif-
icant and complex cross talks among the different pathways exist and are involved
in different aspects of HCC develop...
Từ khóa:
- combinatorial and sequential targeted therapy in metastatic renal cell carcinoma
- dna and dna repair targeted therapy of non clear cell carcinoma
- targeted therapy in squamous cell carcinoma of the head and neck
- cells cancer stem cells and hepatocellular carcinoma
- herbs and bioactive compounds in prevention and treatment of hepatocellular carcinoma
- stat transcription factors in tumor development and targeted therapy of malignancies
- 10 treatment of hepatocellular carcinoma and liver metastases
- 4 molecular biology of germ cell tumors and effect of targeted therapy